Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Relationship of Serum Apolipoprotein A-V Levels, Oxidative Stress and Inflammatory Biomarkers with Hypertriglyceridemia in Type 2 Diabetes Mellitus.

Sharma D, Garg S, Mehndiratta M, V Madhu S, Puri D.

Int J Endocrinol Metab. 2017 Apr 22;15(2):e44805. doi: 10.5812/ijem.44805. eCollection 2017 Apr.

2.

Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice.

Zhang LS, Xu M, Yang Q, Ryan RO, Howles P, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Apr 1;308(7):G634-42. doi: 10.1152/ajpgi.00339.2014. Epub 2015 Jan 23.

3.

Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.

Halalkhor S, Jalali F, Tilaki KH, Shojaei S.

J Diabetes Metab Disord. 2014 Apr 7;13:48. doi: 10.1186/2251-6581-13-48. eCollection 2014.

4.

Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Sharma V, Forte TM, Ryan RO.

Curr Opin Lipidol. 2013 Apr;24(2):153-9. doi: 10.1097/MOL.0b013e32835c8c1a. Review.

5.

The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Garelnabi M, Lor K, Jin J, Chai F, Santanam N.

Clin Biochem. 2013 Jan;46(1-2):12-9. doi: 10.1016/j.clinbiochem.2012.09.007. Epub 2012 Sep 19. Review.

6.

Influence of apolipoprotein A-V on hepatocyte lipid droplet formation.

Gao X, Forte TM, Ryan RO.

Biochem Biophys Res Commun. 2012 Oct 19;427(2):361-5. doi: 10.1016/j.bbrc.2012.09.065. Epub 2012 Sep 18.

7.

Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion.

Blade AM, Fabritius MA, Hou L, Weinberg RB, Shelness GS.

J Lipid Res. 2011 Feb;52(2):237-44. doi: 10.1194/jlr.M010793. Epub 2010 Nov 26.

8.
9.

Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.

Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH.

J Lipid Res. 2010 Nov;51(11):3281-8. doi: 10.1194/jlr.M010330. Epub 2010 Aug 27.

10.

Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation.

Shu X, Nelbach L, Ryan RO, Forte TM.

Biochim Biophys Acta. 2010 May;1801(5):605-8. doi: 10.1016/j.bbalip.2010.02.004. Epub 2010 Feb 11.

11.

Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin.

Smith CE, Tucker KL, Lai CQ, Parnell LD, Lee YC, Ordovás JM.

Obesity (Silver Spring). 2010 Feb;18(2):327-32. doi: 10.1038/oby.2009.216. Epub 2009 Jul 23.

12.

Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.

Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, Parnell LD, Garcia-Rios A, Ordovas JM, Lopez-Miranda J.

J Lipid Res. 2010 Jan;51(1):63-73. doi: 10.1194/jlr.M800527-JLR200.

13.

Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.

Pamir N, McMillen TS, Li YI, Lai CM, Wong H, LeBoeuf RC.

Metabolism. 2009 Apr;58(4):560-7. doi: 10.1016/j.metabol.2008.11.018.

14.

Nutrigenomics: a case for the common soil between cardiovascular disease and cancer.

Iacoviello L, Santimone I, Latella MC, de Gaetano G, Donati MB.

Genes Nutr. 2008 Apr;3(1):19-24. doi: 10.1007/s12263-008-0079-0.

15.

The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture.

Wong K, Beckstead JA, Lee D, Weers PM, Guigard E, Kay CM, Ryan RO.

Biochemistry. 2008 Aug 19;47(33):8768-74. doi: 10.1021/bi800515c. Epub 2008 Jul 25.

16.

Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.

Hahne P, Krempler F, Schaap FG, Soyal SM, Höffinger H, Miller K, Oberkofler H, Strobl W, Patsch W.

J Intern Med. 2008 Nov;264(5):452-62. doi: 10.1111/j.1365-2796.2008.01987.x. Epub 2008 Jun 3.

17.

Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.

Shu X, Ryan RO, Forte TM.

J Lipid Res. 2008 Aug;49(8):1670-6. doi: 10.1194/jlr.M800111-JLR200. Epub 2008 Apr 30.

18.

Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene.

Ward KJ, Ellard S, Yajnik CS, Frayling TM, Hattersley AT, Venigalla PN, Chandak GR.

Lipids Health Dis. 2006 May 2;5:11.

19.

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

Marçais C, Verges B, Charrière S, Pruneta V, Merlin M, Billon S, Perrot L, Drai J, Sassolas A, Pennacchio LA, Fruchart-Najib J, Fruchart JC, Durlach V, Moulin P.

J Clin Invest. 2005 Oct;115(10):2862-9.

20.

Give me A5 for lipoprotein hydrolysis!

Merkel M, Heeren J.

J Clin Invest. 2005 Oct;115(10):2694-6. Review.

Supplemental Content

Support Center